2' Modified Oligonucleotides
First Claim
Patent Images
1. An oligonucleotide having the formula ##STR6## or a salt thereof, wherein each B is independently a protected or unprotected purine or pyrimidine base in the β
- -anomeric configuration;
W3 and W4 are each independently H, PO3-2, a protecting group, or an intermediate moiety in the formation of an internucleotide link which when reacted with the appropriate --OH results in Z;
each Z independently is P(O)O, P(O)S or P(O)N(R)2 ;
each R is independently H or alkyl (1-6 C);
n is an integer of 1-200;
each A is independently selected from the group consisting of --X--Y, H, OH or --OPr wherein Pr is a protecting group whereinX is O;
Y is substituted alkyl (2-20 C) or substituted or unsubstituted alkenyl (2-20 C), wherein the substituents are a halogen, OH, NH2, SH, --O--, --CH2 CONH2, --CH2 COOCH2 CH3 or --CH2 CONHCH2 CH2 NH2 ; and
wherein at least one A is X--Y.
1 Assignment
0 Petitions
Accused Products
Abstract
Oligomers which have substituents on the 2'"'"' position are resistant to oligonucleases and furthermore can be derivatized to deliver reagents or drugs, to carry label, or to provide other properties.
-
Citations
35 Claims
-
1. An oligonucleotide having the formula ##STR6## or a salt thereof, wherein each B is independently a protected or unprotected purine or pyrimidine base in the β
- -anomeric configuration;
W3 and W4 are each independently H, PO3-2, a protecting group, or an intermediate moiety in the formation of an internucleotide link which when reacted with the appropriate --OH results in Z; each Z independently is P(O)O, P(O)S or P(O)N(R)2 ; each R is independently H or alkyl (1-6 C); n is an integer of 1-200; each A is independently selected from the group consisting of --X--Y, H, OH or --OPr wherein Pr is a protecting group wherein X is O; Y is substituted alkyl (2-20 C) or substituted or unsubstituted alkenyl (2-20 C), wherein the substituents are a halogen, OH, NH2, SH, --O--, --CH2 CONH2, --CH2 COOCH2 CH3 or --CH2 CONHCH2 CH2 NH2 ; and wherein at least one A is X--Y. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27)
- -anomeric configuration;
-
28. An oligonucleotide having the formula ##STR7## or a salt thereof, wherein each B is independently a protected or unprotected purine or pyrimidine base in the β
- -anomeric configuration;
W3 and W4 are each independently H, PO3-2, a protecting group, or an intermediate moiety in the formation of an internucleotide link which when reacted with the appropriate --OH results in Z; each Z independently is --P(O)O--, --P(O)S-- or --P(O)N(R)2 --; each R is independently H or alkyl (1-6 C); n is an integer of 1-200; each A is independently selected from the group consisting of --X--Y, --H, --OH or --OPr wherein Pr is a protecting group, wherein X is --CH2 --, --S-- or --NH--; Y is substituted alkyl (2-20 C) or substituted or unsubstituted alkenyl (2-20 C), wherein the substituents are a halogen, --OH, --NH2, --SH, --O--, --CH2 CONH2, --CH2 COOCH2 CH3 or --CH2 CONHCH2 CH2 NH2 ; and wherein at least one A is --X--Y. - View Dependent Claims (29, 30, 31, 32, 33, 34)
- -anomeric configuration;
-
35. An oligonucleotide having the formula ##STR8## or a salt thereof, wherein each B is independently a protected or unprotected purine or pyrimidine base in the β
- anomeric configuration;
W3 and W4 are each independently H, PO3-2, a protecting group, or an intermediate moiety in the formation of an internucleotide link which when reacted with the appropriate --OH results in Z; each Z independently is --P(O)O--, --P(O)S-- or --P(O)N(R)2 --; each R is independently --H or alkyl (1-6 C); n is an integer of 1-200; each A is independently selected from the group consisting of --X--Y, --H, --OH or --OPr wherein Pr is a protecting group wherein X is --O--; Y is substituted alkyl (2-20 C) or substituted or unsubstituted alkenyl (2-20 C), wherein the substituents are a halogen, --OH, --NH2, --SH, --O--, --COOH, --C(O)--, --CH2 COOH, --CH2 CONH2, --CH2 COOCH2 CH3 or --CH2 CONHCH2 CH2 NH2 ; and wherein at least one A is --X--Y.
- anomeric configuration;
Specification